Tybourne Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-768,603	Closed	-$14.8M	–	27
2022 Q2	$14.8M	Hold	768,603	–	–	1.07%	24
2022 Q1	$9.88M	Buy	+768,603	New	+$9.88M	0.58%	26